COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Available online: https://covid19.who.int/ (accessed on 11 February 2021).
- Rubin, R. The challenges of expanding rapid tests to curb COVID-19. JAMA 2020, 324, 1813–1815. [Google Scholar] [CrossRef] [PubMed]
- Mina, M.J.; Parker, R.; Larremore, D.B. Rethinking Covid-19 test sensitivity—A strategy for containment. N. Engl. J. Med. 2020, 383, e120. [Google Scholar] [CrossRef] [PubMed]
- Vandenberg, O.; Martiny, D.; Rochas, O.; van Belkum, A.; Kozlakidis, Z. Considerations for diagnostic COVID-19 tests. Nat. Rev. Microbiol. 2020, 19, 171–183. [Google Scholar] [CrossRef] [PubMed]
- WHO. Antigen-Detection in the Diagnosis of SARS-CoV-2 Infection Using Rapid Immunoassays: Interim Guidance. Available online: https://apps.who.int/iris/handle/10665/334253 (accessed on 11 September 2020).
- Fomsgaard, A.S.; Rosenstierne, M.W. An alternative workflow for molecular detection of SARS-CoV-2—Escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020. Eurosurveillance 2020, 25, 2000398. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mak, G.C.; Cheng, P.K.; Lau, S.S.; Wong, K.K.; Lau, C.S.; Lam, E.T.; Chan, R.C.; Tsang, D.N. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. J. Clin. Virol. 2020, 129, 104500. [Google Scholar] [CrossRef] [PubMed]
- Lai, C.K.C.; Lam, W. Laboratory testing for the diagnosis of COVID-19. Biochem. Biophys. Res. Commun. 2021, 538, 226–230. [Google Scholar] [CrossRef] [PubMed]
- Krüger, L.J.; Gaeddert, M.; Köppel, L.; Brümmer, L.E.; Gottschalk, C.; Miranda, I.B.; Schnitzler, P.; Kraeusslich, H.G.; Lindner, A.; Nikolai, O.; et al. Evaluation of the accuracy, ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for SARS-CoV-2. medRxiv 2020. [Google Scholar] [CrossRef]
- Nalumansi, A.; Lutalo, T.; Kayiwa, J.; Watera, C.; Balinandi, S.; Kiconco, J.; Nakaseegu, J.; Olara, D.; Odwilo, E.; Serwanga, J.; et al. Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples. Int. J. Infect. Dis. 2020, 104, 282–286. [Google Scholar] [CrossRef] [PubMed]
- Istituto Superiore di Sanità. Nota tecnica ad interim. Test di laboratorio per SARS-CoV-2 e loro uso in sanità pubblica; Ministero della Salute—Istituto Superiore di Sanità: Rome, Italy, 2020.
- Center for Disease Control and Prevention (CDC). Interim Guidance for Rapid Antigen Testing for SARS-CoV-2. Available online: https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guidelines.html (accessed on 11 February 2021).
- Ministero della Salute. Disposizioni Attuative del Decreto-Legge 25 Marzo 2020, n. 19, Recante Misure Urgenti per Fronteggiare L’Emergenza Epidemiologica da COVID-19, e del Decreto-Legge 16 Maggio 2020, n. 33, Recante Ulteriori Misure Urgenti per Fronteggiare l’Emergenza Epidemiologica da COVID-19, 20A02717; Ministero della Salute: Rome, Italy, 2020.
- Liotti, F.M.; Menchinelli, G.; Lalle, E.; Palucci, I.; Marchetti, S.; Colavita, F. Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples. Clin. Microbiol. Infect. 2020, 27, 487–488. [Google Scholar] [CrossRef] [PubMed]
- Colavita, F.; Lapa, D.; Carletti, F.; Lalle, E.; Messina, F.; Rueca, M. Virological characterization of the first two COVID-19 patients diagnosed in Italy: Phylogenetic analysis, virus shedding profile from different body sites and antibody response kinetics. Open Forum Infect. Dis. 2020, 7, ofaa403. [Google Scholar] [CrossRef] [PubMed]
- Cerutti, F.; Burdino, E.; Milia, M.G.; Allice, T.; Gregori, G.; Bruzzone, B.; Ghisetti, V. Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2. J. Clin. Virol. 2020, 132, 104654. [Google Scholar] [CrossRef] [PubMed]
- Porte, L.; Legarraga, P.; Vollrath, V.; Aguilera, X.; Munita, J.M.; Araos, R. Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. Int. J. Infect. Dis. 2020, 99, 328–333. [Google Scholar] [CrossRef] [PubMed]
- World Health Organization. COVID-19 Strategic Preparedness and Response Plan Operational Planning Guidelines to Support Country Preparedness and Response. 2020. Available online: https://www.who.int/docs/default-source/coronaviruse/covid-19-sprp-unct-guidelines.pdf?sfvrsn=81ff43d8_4 (accessed on 11 February 2021).
- Pettengill, M.A.; McAdam, A.J. Can we test our way out of the COVID-19 pandemic? J. Clin. Microbiol. 2020, 58, e02225-20. [Google Scholar] [CrossRef] [PubMed]
COI | RT-PCR Positive/N (% TP) | % FP by FIA |
---|---|---|
≥1 | 207/603 (34.3%) | 65.7% |
≥3 | 186/228 (81.6%) | 18.4% |
≥5 | 175/188 (93.1%) | 6.9% |
≥8 | 159/165 (96.4%) | 3.6% |
≥10 | 152/154 (98.7%) | 1.3% |
≥15 | 138/139 (99.3%) | 0.7% |
≥20 | 127/127 (100%) | 0.0% |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Colavita, F.; Vairo, F.; Meschi, S.; Valli, M.B.; Lalle, E.; Castilletti, C.; Fusco, D.; Spiga, G.; Bartoletti, P.; Ursino, S.; et al. COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020. Biomolecules 2021, 11, 425. https://doi.org/10.3390/biom11030425
Colavita F, Vairo F, Meschi S, Valli MB, Lalle E, Castilletti C, Fusco D, Spiga G, Bartoletti P, Ursino S, et al. COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020. Biomolecules. 2021; 11(3):425. https://doi.org/10.3390/biom11030425
Chicago/Turabian StyleColavita, Francesca, Francesco Vairo, Silvia Meschi, Maria Beatrice Valli, Eleonora Lalle, Concetta Castilletti, Danilo Fusco, Giuseppe Spiga, Pierluigi Bartoletti, Simona Ursino, and et al. 2021. "COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020" Biomolecules 11, no. 3: 425. https://doi.org/10.3390/biom11030425